Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-15,511
Closed -$725K 2009
2025
Q1
$725K Buy
15,511
+5,098
+49% +$263K 0.02% 628
2024
Q4
$533K Buy
10,413
+1,751
+20% +$90.7K 0.01% 788
2024
Q3
$385K Buy
+8,662
New +$379K 0.01% 1425
2024
Q2
Sell
-19,261
Closed -$772K 2475
2024
Q1
$772K Buy
19,261
+3,575
+23% +$134K 0.02% 784
2023
Q4
$591K Buy
15,686
+1,926
+14% +$58.9K 0.01% 876
2023
Q3
$383K Buy
+13,760
New +$430K 0.01% 1073
2021
Q4
Sell
-18,123
Closed -$795K 1514
2021
Q3
$795K Buy
+18,123
New +$766K 0.05% 413
2021
Q2
Sell
-12,289
Closed -$562K 1606
2021
Q1
$562K Buy
+12,289
New +$515K 0.02% 517
2020
Q2
Sell
-31,438
Closed -$552K 800
2020
Q1
$552K Buy
+31,438
New +$968K 0.02% 299
2019
Q4
Sell
-15,461
Closed -$553K 916
2019
Q3
$553K Buy
+15,461
New +$555K 0.03% 307

Other funds holding SNV

Centiva Capital's SNV Position: Q2 2025 in Review

Centiva Capital sold out of Synovus (SNV) in Q2 2025, closing a stake of 15,511 shares — an estimated $725K sold.

Centiva Capital first reported a position in SNV in Q3 2019 and held it in 10 quarters. The position peaked at $795K in Q3 2021. 476 funds tracked by Wall St. Rank hold SNV as of Q2 2025.

  • Centiva Capital reported no remaining Synovus position as of Q2 2025 after selling out during the quarter.
  • Centiva Capital sold 15,511 Synovus shares in Q2 2025, an estimated $725K.
  • Centiva Capital first reported a position in Synovus in Q3 2019 and held it in 10 quarters.
  • Centiva Capital's Synovus position peaked at $795K in Q3 2021.
  • 476 funds tracked by Wall St. Rank held Synovus as of Q2 2025.

Based on Centiva Capital's 13F filing for Q2 2025, filed 13 Aug 2025.